Literature DB >> 24074490

Role of gamma knife surgery for intracranial atypical (WHO grade II) meningiomas.

Shunya Hanakita1, Tomoyuki Koga, Hiroshi Igaki, Naoya Murakami, Soichi Oya, Masahiro Shin, Nobuhito Saito.   

Abstract

OBJECT: Atypical meningioma often recurs even after resection. As a salvage modality, radiotherapy or stereotactic radiosurgery (SRS) is attempted for this aggressive tumor. This retrospective study was performed to evaluate the efficacy of SRS that involved Gamma Knife surgery (GKS) for atypical meningioma.
METHODS: The authors reviewed records from 22 patients with histologically proven atypical meningioma who underwent GKS for 28 lesions at the authors' institute. The median patient age was 70 years (range 24-91 years), and the median tumor volume for each procedure was 6.0 cm3 (range 1.6-38.7 cm3). The margin dose ranged from 14 to 20 Gy (median 18 Gy). Follow-up periods ranged from 3 months to 98 months (median 23.5 months).
RESULTS: In total, 39 GKS procedures were performed for 28 lesions. The local control rates at 1, 2, and 5 years were 74%, 39%, and 16%, respectively. Volume less than 6 cm3 (p = 0.01), a margin dose higher than 18 Gy (p = 0.02), and a Karnofsky Performance Scale (KPS) score of 90 or more (p = 0.02) were factors associated with a longer duration of tumor control in the univariate analysis.
CONCLUSIONS: Atypical meningioma could be more successfully controlled when a higher margin dose was used to treat patients with a good performance (KPS score of ≥ 90) status and smaller tumor volumes. It would be desired if patients are treated with a relatively higher margin dose, ideally as high as the dose applied for malignant tumor. A boost SRS after fractionated radiotherapy may be effective to achieve better local control.

Entities:  

Mesh:

Year:  2013        PMID: 24074490     DOI: 10.3171/2013.8.JNS13343

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Proton therapy for atypical meningiomas.

Authors:  Mark W McDonald; David A Plankenhorn; Kevin P McMullen; Mark A Henderson; Edward J Dropcho; Mitesh V Shah; Aaron A Cohen-Gadol
Journal:  J Neurooncol       Date:  2015-04-10       Impact factor: 4.130

2.  Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas.

Authors:  Yu-Chi Wang; Chi-Cheng Chuang; Kuo-Chen Wei; Cheng-Nen Chang; Shih-Tseng Lee; Chieh-Tsai Wu; Yung-Hsin Hsu; Tzu-Kan Lin; Peng-Wei Hsu; Yin-Cheng Huang; Chen-Kan Tseng; Chun-Chieh Wang; Yao-Liang Chen; Pin-Yuan Chen
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

Review 3.  Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues.

Authors:  Lorenzo Vagnoni; Sami Aburas; Martina Giraffa; Ivana Russo; Vito Chiarella; Sergio Paolini; Paolo Tini; Giuseppe Minniti
Journal:  Neurosurg Rev       Date:  2022-06-04       Impact factor: 2.800

4.  Gamma Knife radiosurgery for intracranial meningiomas: Do we need to treat the dural tail? A single-center retrospective analysis and an overview of the literature.

Authors:  Vincent J Bulthuis; Patrick E J Hanssens; Suan Te Lie; Jacobus J van Overbeeke
Journal:  Surg Neurol Int       Date:  2014-09-05

Review 5.  Recent advances in managing/understanding meningioma.

Authors:  Nawal Shaikh; Karan Dixit; Jeffrey Raizer
Journal:  F1000Res       Date:  2018-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.